Hortelano, Roly H.

HRN: 26-90-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2025
04/09/2025
IV
4.5g
Q6
Abdominal Mass Prob Malignant
Waiting Final Action 
04/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/03/2025
04/09/2025
IV
500mg
Q8
Abdominal Mass Prob Malignant
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: